Quality of Life Assessments Utilized in Vitiligo Clinical Trials

Table 1

Proportion of clinical trials assessing QoL measures.

Number of clinical trials by indication (n = 60)	Proportion that assessed a QoL	Breakdown by the trial type (total)	Percent of trials that assessed a QoL by the trial type:	Number of trial per year range
Adult: 60; Children: 0; Both: 11	Adult: 18 (30%); Children: 0 (0%); Both: 6 (54.55%)	Phase 1/2: 4; Phase 2:36; Phase 3:12; Phase 2/3: 8	Phase 1, 2:0 (0%); Phase 2:17 (47.22%); Phase 3:7 (58.33%); Phase 2, 3:0 (0%)	2000–2005:1; 2006–2010:7; 2011–2015:17; 2016–2020:15; 2021–2023:20

QoL = quality of life. Number of studies that used validated QoL: 20/24 = (83.33%). Clinical trials were listed as both listed phases on clinicaltrials.gov.